CTLA-4 -1722T/C Polymorphism and Systemic Lupus Erythematosus Susceptibility: A Meta-analysis Involving Ten Separate Studies

By Zhu Ji-Min  

Immunological Investigations, Vol. 42, Iss. 2, 2013-02 ,pp. : 91-105

Informa Healthcare

Access to resources Recommend Favorite

No Evidence of Association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG Polymorphism with Autoimmune Diabetes

By Caputo Mariela   Cerrone Gloria Edith   Mazza C.   Cédola N.   Targovnik Hector Manuel   Gustavo Daniel Frechtel  

Immunological Investigations, Vol. 36, Iss. 3, 2007-05 ,pp. : 259-270

Informa Healthcare

Access to resources Recommend Favorite

Lack of Association between the IL-13 C-1112T, G2044A Polymorphisms and Graves’ Disease Risk: Evidence from a Meta-analysis

By Chen Min-Li   Liao Ning   Zhao Hua   Huang Jian   Xie Zheng-Fu  

Immunological Investigations, Vol. 43, Iss. 4, 2014-05 ,pp. : 337-348

Informa Healthcare

Access to resources Recommend Favorite

Association of CTLA-4 (++49A/G) Gene Polymorphism with Type 1 Diabetes Mellitus in Egyptian Children

By Mosaad Youssef M.   Elsharkawy Ashraf A.   El-Deek Basem S.  

Immunological Investigations, Vol. 41, Iss. 1, 2012-01 ,pp. : 28-37

Informa Healthcare

Access to resources Recommend Favorite

Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes

By Ide A.   Kawasaki E.   Abiru N.   Sun F.   Kobayashi M.   Fukushima T.   Takahashi R.   Kuwahara H.   Kita A.   Oshima K.   Uotani S.   Yamasaki H.   Yamaguchi Y.   Eguchi K.  

Journal of Autoimmunity, Vol. 22, Iss. 1, 2004-02 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite